Poxel SA
OTC:PXXLF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Poxel SA
OTC:PXXLF
|
FR |
|
J
|
Jack Henry & Associates Inc
XMUN:JHY
|
US |
|
C
|
CenterPoint Energy Inc
SWB:HOU
|
US |
|
Aminex PLC
F:DOP
|
UK |
|
G
|
Garmin Ltd
SWB:GEY
|
CH |
|
F
|
First Merchants Corp
F:FM5
|
US |
|
Marimaca Copper Corp
F:E2E
|
CL |
|
Astarta Holding PLC
OTC:ASTPF
|
CY |
|
Sanden Corp
F:SOE1
|
JP |
Intrinsic Value
Is PXXLF undervalued or overvalued?
See the intrinsic value estimate for 
Poxel SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Poxel Does
Poxel SA is a French biopharmaceutical company that focuses on drugs for metabolic diseases, especially type 2 diabetes and related liver disorders. It does not sell a broad range of medicines; instead, it develops a small number of drug candidates and works through partners to bring them to market. Its best-known program is imeglimin, a diabetes treatment that has been developed with commercial partners in Asia.
- Headquarters
- France FR
- Employees
- 5
- IPO date
- Feb 6, 2015
Earnings Waterfall
Poxel SA
The intrinsic value for Poxel SA (PXXLF) under the Base Case is hidden USD.
Compared with the current market price of 2.1 USD, the stock appears hidden.